EU-funded Parkinson’s research project launched at University of Luxembourg

News

Author: Almaz OhenePublished: 9 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The EU is funding a €5.9 million research project at the University of Luxembourg that aims to develop new techniques to identify active compounds for use in the treatment of Parkinson’s disease.

Researchers will concentrate on patterns of Parkinson’s disease in which the mitochondria – the part of the cell that takes in nutrients – are damaged by mutations in individual genes.

The project, Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD), brings together partner institutions and pharmaceutical companies from across Europe such as Luxembourg, Germany, Ireland, the Netherlands and the UK.

Dr Ronan Fleming, LCSB scientist and SysMedPD coordinator, said: “We estimate that in about 10-20% of all Parkinson’s patients, their mitochondria do not function properly. In order to better diagnose, heal or at least effectively curb the progression of Parkinson’s disease, we must understand this dysfunction of mitochondria in detail.”

Go Back

Share this story

Comments


Related articles


The Parkili team

Perspectives

Parkili: moving mountains for Parkinson’s

Mirjam was diagnosed in 2014, she's now climbed Kilimanjaro

READ MORE
80417_PL_Tim Hague Sr lead

Perspectives

World Parkinson Congress 2019 Bloggers: Tim Hague

#WPC2019: We talk to Canadian blogger Tim Hague Sr

READ MORE
wpc-preview-lead

Global update

What to expect: the fourth World Parkinson Congress

We take a look at what you can expect in Portland

READ MORE